Transplantation and Cellular Therapy
Scope & Guideline
Pioneering Research for Tomorrow's Medical Breakthroughs.
Introduction
Aims and Scopes
- Hematopoietic Stem Cell Transplantation (HSCT):
The journal extensively covers various aspects of HSCT, including donor selection, conditioning regimens, post-transplant complications, and long-term outcomes, reflecting the complexities and advancements in this critical area of transplant medicine. - Chimeric Antigen Receptor (CAR) T-Cell Therapy:
A significant focus is placed on CAR T-cell therapies, including their efficacy, safety, and integration with HSCT. The journal explores the evolving landscape of CAR therapies, especially in hematologic malignancies. - Graft-Versus-Host Disease (GVHD):
Research on GVHD prevention, diagnosis, management, and outcomes is a core area, emphasizing its impact on patient survival and quality of life post-transplant. - Infection Management in Transplant Recipients:
The journal addresses the challenges of infectious diseases in transplant patients, including prophylaxis, treatment strategies, and the impact of infections on transplant outcomes. - Patient-Reported Outcomes and Quality of Life:
There is a growing emphasis on understanding the patient experience, mental health, and quality of life following transplantation, highlighting the holistic approach to patient care. - Emerging Therapies and Novel Approaches:
The journal promotes research on new therapeutic strategies, including novel drugs, immunotherapies, and precision medicine approaches that enhance transplantation outcomes. - Health Disparities and Access to Care:
Investigations into the socioeconomic, racial, and geographic disparities in access to transplantation and cellular therapies are increasingly prominent, reflecting a commitment to equitable healthcare.
Trending and Emerging
- Integration of Telehealth in Transplant Care:
The adoption of telehealth solutions for pre- and post-transplant care is becoming increasingly popular, particularly in response to the COVID-19 pandemic, emphasizing the need for accessible patient management. - Advanced Biomarkers for Predicting Outcomes:
Research focusing on the development and validation of biomarkers to predict transplant outcomes is on the rise, aiding in personalized medicine approaches for transplant recipients. - Psychosocial Aspects of Transplantation:
There is a growing interest in the psychosocial impact of transplantation on patients and caregivers, including mental health, coping strategies, and support systems. - Innovations in GVHD Management:
New strategies and therapies aimed at preventing and treating GVHD are gaining prominence, reflecting the ongoing challenges associated with this condition. - Diversity and Inclusion in Transplant Research:
The journal increasingly emphasizes studies addressing health disparities, focusing on diverse populations and the impact of social determinants on transplantation outcomes. - Long-Term Survivorship and Late Effects:
Research addressing the long-term effects of transplantation and the survivorship experience is emerging as a vital area of inquiry, focusing on health maintenance and quality of life. - Innovative Cellular Therapies Beyond CAR T-Cells:
The exploration of new cellular therapies, such as TCR-engineered cells and NK cell therapies, is gaining momentum as researchers seek to expand treatment options for various malignancies.
Declining or Waning
- Traditional Conditioning Regimens:
As new conditioning regimens and personalized approaches are developed, traditional conditioning methods are receiving less emphasis, indicating a shift toward more innovative strategies. - Longitudinal Studies of Established Procedures:
Research that focuses on well-established transplantation procedures is becoming less frequent, possibly due to the saturation of existing knowledge and the shift towards novel therapies and techniques. - Basic Science of Hematopoiesis:
While foundational research remains important, there is a noticeable decline in basic science studies related to hematopoiesis as the journal pivots towards clinical applications and translational research. - Cost-Effectiveness Analyses:
Although economic evaluations are still relevant, their frequency appears to be waning as the focus shifts towards clinical efficacy and patient outcomes rather than purely economic considerations. - Single-Center Studies:
Research output from single centers is decreasing, with a trend towards multicenter collaborative studies that provide broader insights and enhance the generalizability of findings.
Similar Journals
INTERNATIONAL JOURNAL OF HEMATOLOGY
Elevating Hematology Research to New HeightsThe INTERNATIONAL JOURNAL OF HEMATOLOGY, published by SPRINGER JAPAN KK, serves as a critical platform for advancing research in the field of hematology. With a prestigious history spanning over three decades from 1991 to 2024, this journal is recognized for its impactful contributions, evidenced by its Q2 category ranking in Hematology for 2023, and its notable position at rank #71 out of 137 in the Scopus Medicine Hematology category. Researchers and professionals within the hematology community benefit from the journal's rigorous peer-reviewed articles that cover a wide range of topics, including clinical studies, basic research, and novel therapeutic strategies. Though currently non-open access, it provides essential insights and findings to an audience passionate about the latest advancements in blood disorders and treatments. Situated in Japan, the journal not only showcases high-quality research but also fosters a global exchange of knowledge in hematology, making it a significant resource for scholars, practitioners, and students alike.
Egyptian Journal of Haematology
Navigating the Future of Hematology with Rigorous ResearchThe Egyptian Journal of Haematology, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of hematology, particularly within the context of Egypt and the broader Middle Eastern region. This journal is dedicated to disseminating high-quality research that explores the latest advancements in blood disorders, hematologic malignancies, and transfusion medicine. With a focus on original research, case studies, and reviews, it aims to provide a comprehensive platform for hematologists, researchers, and healthcare professionals to enhance their understanding and management of hematological conditions. Although it is not an open-access journal, the rigorous peer-review process ensures that only the most impactful studies are published, contributing to the journal's reputation in the academic community. The Egyptian Journal of Haematology serves as an essential tool for advancing knowledge, improving clinical outcomes, and fostering collaboration among experts in the field.
TRANSPLANT INTERNATIONAL
Leading the Charge in Transplant InnovationsTRANSPLANT INTERNATIONAL is a premier open-access journal in the field of transplantation, published by Frontiers Media SA since 1988. With its dedicated scope encompassing the latest research and advancements in organ transplantation and related fields, this journal serves as an essential resource for researchers, clinicians, and healthcare professionals engaged in transplantation medicine. Boasting an impressive 2023 Scopus rank of #17 out of 54 in the Medicine - Transplantation category and a Q2 quartile ranking, it has established itself as a vital publication platform contributing to the global discourse on transplant innovations. As an open-access journal since 2022, TRANSPLANT INTERNATIONAL enhances the dissemination of knowledge, ensuring that pivotal findings are accessible to a broader audience, thereby fostering advancements in patient care and clinical practices. With its base in Italy and operations managed from Lausanne, Switzerland, the journal promises to remain at the forefront of transplantation research through 2024 and beyond.
EUROPEAN JOURNAL OF HAEMATOLOGY
Advancing Hematology Research for a Healthier TomorrowEUROPEAN JOURNAL OF HAEMATOLOGY, published by Wiley, serves as a vital resource for experts in the field of hematology, focusing on the latest advancements in blood disorders and therapies. With an ISSN of 0902-4441 and an E-ISSN of 1600-0609, this esteemed journal has been disseminating knowledge since 1986 and continues to thrive, converging its visionary approach through to 2024. Notably, it holds a distinguished Q2 ranking in Hematology and an impressive Q1 ranking in the broader category of Medicine (miscellaneous) as of 2023, highlighting its significant contribution to the scientific community. With a Scopus rank of #45/137 and a 67th percentile in the field, the journal is recognized for its rigorous peer-reviewed research, making it an indispensable publication for researchers, practitioners, and students aiming to stay at the forefront of hematological studies. Though not an open-access journal, it ensures broad accessibility to critical findings via its subscription model, thus fostering an informed and globally engaged audience.
International Journal of Molecular and Cellular Medicine
Advancing the Frontiers of Molecular and Cellular ScienceInternational Journal of Molecular and Cellular Medicine, published by the CELLULAR & MOLECULAR BIOLOGY RESEARCH CENTER in Iran, is a leading platform dedicated to advancing research in various domains of molecular and cellular sciences. With an ISSN of 2251-9637 and E-ISSN 2251-9645, this journal features a rigorous peer-review process that ensures the publication of high-quality, impactful research. Spanning from 2016 to 2024, it is categorized in the third quartile (Q3) in Biochemistry, Cell Biology, Genetics, and Molecular Biology, and second quartile (Q2) in Biotechnology, underlining its significance in the scientific community. Although currently non-open access, it maintains credible visibility through Scopus rankings, reflecting its importance in fields such as Biochemistry, Molecular Medicine, and Genetics, where it holds respectable ranks and percentiles. This journal aims to foster collaboration and knowledge dissemination among researchers, professionals, and students in the pursuit of enhancing understanding and innovation in molecular and cellular medicine.
Iraqi Journal of Hematology
Empowering Research, Enhancing Patient CareIraqi Journal of Hematology is a prominent peer-reviewed open-access journal dedicated to advancing the field of hematology. Published by Wolters Kluwer Medknow Publications, this journal provides a platform for researchers, professionals, and students to share cutting-edge findings and developments in various aspects of hematology, including blood diseases, diagnostics, and innovative treatments. Since its transition to open access in 2016, the journal has significantly increased its reach, allowing for wider dissemination of critical research to a global audience. With an ISSN of 2072-8069 and an E-ISSN of 2543-2702, the Iraqi Journal of Hematology strives to adhere to the highest scholarly standards and plays a vital role in the ongoing discourse in hematological research. Researchers are encouraged to contribute to this essential resource for the scientific community, contributing to the advancement of knowledge that ultimately improves patient care and treatment outcomes.
Blood Science
Pioneering Research for Better Blood HealthBlood Science is a distinguished peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the dynamic field of hematology. Since its inception, the journal has aimed to disseminate high-quality research and innovative findings that contribute to our understanding of blood-related health issues. With the ISSN 2543-6368, it offers a platform for academic discussions and breakthroughs in various subfields including hematopathology, blood disorders, and transfusion medicine. As of 2023, Blood Science is ranked in the third quartile (Q3) within the hematology category, indicating a burgeoning influence among its peers, with a Scopus rank of #101 out of 137 journals, placing it in the 26th percentile. Although it is not an open-access journal, it provides essential insights and valuable data for researchers, healthcare professionals, and students alike, enhancing the collective knowledge and practices in hematology. With a publication period spanning from 2019 to 2024, Blood Science remains committed to fostering the advancement of blood science research and enhancing patient care methodologies.
JOURNAL OF HEART AND LUNG TRANSPLANTATION
Connecting Clinicians and Researchers for a Healthier TomorrowJOURNAL OF HEART AND LUNG TRANSPLANTATION, published by Elsevier Science Inc., serves as a premier platform for researchers and clinicians in the fields of Cardiology, Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery, and Transplantation. Since its inception in 1991, this esteemed journal has maintained a robust impact within the scientific community, currently holding a remarkable Q1 ranking in multiple categories as of 2023, indicative of its influential contributions to the field. With Scopus rankings placing it among the top ten in Surgery and fourth in Transplantation, it is essential reading for those looking to stay at the forefront of innovative transplantation techniques and cardiovascular research. Although not an open access journal, its rich content is crucial for advancing knowledge and promoting best practices, making it indispensable for professionals, students, and researchers dedicated to the life-saving field of heart and lung transplantation. The journal continues to foster academic excellence and facilitate impactful research, addressing contemporary challenges and innovations within these critical areas.
TRANSPLANTATION
Empowering Professionals with Cutting-edge Transplant Research.TRANSPLANTATION is a premier journal in the field of organ transplantation, published by Lippincott Williams & Wilkins, that has been a cornerstone of transplantation research since its inception in 1963. With an impressive impact factor cementing its status, this journal is categorized in the top quartile (Q1) of its field, currently ranking 6th out of 54 in the Scopus Medicine Transplantation category, placing it in the 89th percentile. The journal publishes original research, clinical studies, and reviews that significantly advance our understanding of transplantation science, ensuring that professionals, researchers, and students remain informed of the latest developments. Although it is not an open-access journal, it offers valuable insights that contribute to enhancing practice and improving outcomes in transplantation medicine, making it an essential resource for anyone involved in this dynamic and impactful discipline.
Transplant Immunology
Pioneering Research at the Intersection of Immunology and Transplantation.Transplant Immunology is a leading interdisciplinary journal published by Elsevier, dedicated to the advancing field of transplant science and immunology. With a strong reputation in the academic community, it currently holds a significant position in the Q3 quartile in both the Immunology and Allergy categories, as well as Q2 in Transplantation, reflecting its impact and relevance within these fields. Since its inception in 1993, the journal has explored a broad spectrum of topics, ranging from immunological mechanisms to clinical aspects of transplantation, serving as a vital resource for researchers, healthcare professionals, and students alike. Although it is not an open-access journal, it offers critical insights and innovative research findings that bridge theoretical knowledge and practical application, thereby enhancing our understanding of transplant immunology. As the field continues to evolve, Transplant Immunology remains committed to publishing high-quality studies that advance the dialogue between immunology and transplantation, fostering collaboration and discovery.